Terms: = Breast cancer AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990
47 results:
1. Association Between a History of breast cancer and Decreased Thyroid cancer-specific Mortality.
Lin S; Wang Z; Xing M
J Clin Endocrinol Metab; 2024 Apr; 109(5):1222-1230. PubMed ID: 38064679
[TBL] [Abstract] [Full Text] [Related]
2. A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.
Bauer TM; Moore KN; Rader JS; Simpkins F; Mita AC; Beck JT; Hart L; Chu Q; Oza A; Tinker AV; Imedio ER; Kumar S; Mugundu G; Jenkins S; Chmielecki J; Jones S; Spigel D; Fu S
Target Oncol; 2023 Jul; 18(4):517-530. PubMed ID: 37278879
[TBL] [Abstract] [Full Text] [Related]
3. Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer.
Guo Q; Lan T; Lu Y; Hu Z; Xu H; Wang X; Shao X; Fu X
Biomol Biomed; 2023 May; 23(3):502-509. PubMed ID: 36408954
[TBL] [Abstract] [Full Text] [Related]
4. Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations.
Li K; Cao L; Li C; Wu J; Chen B; Zhang G; Li X; Wen L; Jia M; Wei G; Lin J; Li Y; Zhang Y; Mok H; Ren C; Wang Y; Qi X; Guo L; Che Y; Liao N
Cancer Med; 2023 Mar; 12(5):5195-5208. PubMed ID: 36404592
[TBL] [Abstract] [Full Text] [Related]
5. [Susceptibility study on the germline rare variants of bromodomain and extraterminal domain protein family-encoding genes and patients with cancer living in some regions of China].
Huang Y; Li JH; Wang X; Zou Y; Huang WF; Liu C; Zhang H
Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(42):3374-3381. PubMed ID: 36372767
[No Abstract] [Full Text] [Related]
6. mycl promotes the progression of triple‑negative breast cancer by activating the JAK/STAT3 pathway.
Jiang H; Li X; Wang W; Hu Y; Ren D
Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36177900
[TBL] [Abstract] [Full Text] [Related]
7. Effectiveness of preoperative stretchings on postoperative shoulder function in patients undergoing mastectomy.
Fatima T; Shakoor A; Ilyas M; Safdar M; Majeed S
J Pak Med Assoc; 2022 Apr; 72(4):625-628. PubMed ID: 35614590
[TBL] [Abstract] [Full Text] [Related]
8. Recreational Physical Activity and Outcomes After breast cancer in Women at High Familial Risk.
Kehm RD; MacInnis RJ; John EM; Liao Y; Kurian AW; Genkinger JM; Knight JA; Colonna SV; Chung WK; Milne R; Zeinomar N; Dite GS; Southey MC; Giles GG; McLachlan SA; Whitaker KD; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Phillips KA; Andrulis IL; Buys SS; Daly MB; Hopper JL; Terry MB
JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34950851
[TBL] [Abstract] [Full Text] [Related]
9. MYC Activity Inference Captures Diverse Mechanisms of Aberrant MYC Pathway Activation in Human cancers.
Schaafsma E; Zhao Y; Zhang L; Li Y; Cheng C
Mol Cancer Res; 2021 Mar; 19(3):414-428. PubMed ID: 33234576
[TBL] [Abstract] [Full Text] [Related]
10. Long-term Consequences of Undiagnosed Celiac Seropositivity.
Kårhus LL; Skaaby T; Petersen J; Madsen AL; Thuesen BH; Schwarz P; Rumessen JJ; Linneberg A
Am J Gastroenterol; 2020 Oct; 115(10):1681-1688. PubMed ID: 32558687
[TBL] [Abstract] [Full Text] [Related]
11. breast cancer screening disparities between women with and without disabilities: A national database study in South Korea.
Shin DW; Yu J; Cho J; Lee SK; Jung JH; Han K; Kim SY; Yoo JE; Yeob KE; Kim YY; Park JH; Park JH; Kawachi I
Cancer; 2020 Apr; 126(7):1522-1529. PubMed ID: 31904881
[TBL] [Abstract] [Full Text] [Related]
12. Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.
Hida AI; Watanabe T; Sagara Y; Kashiwaba M; Sagara Y; Aogi K; Ohi Y; Tanimoto A
Breast Cancer Res Treat; 2019 Nov; 178(2):283-294. PubMed ID: 31402409
[TBL] [Abstract] [Full Text] [Related]
13. MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.
Kalkat M; Resetca D; Lourenco C; Chan PK; Wei Y; Shiah YJ; Vitkin N; Tong Y; Sunnerhagen M; Done SJ; Boutros PC; Raught B; Penn LZ
Mol Cell; 2018 Dec; 72(5):836-848.e7. PubMed ID: 30415952
[TBL] [Abstract] [Full Text] [Related]
14. Multiple primary non-breast tumors in breast cancer survivors.
Corso G; Veronesi P; Santomauro GI; Maisonneuve P; Morigi C; Peruzzotti G; Intra M; Sacchini V; Galimberti V
J Cancer Res Clin Oncol; 2018 May; 144(5):979-986. PubMed ID: 29502170
[TBL] [Abstract] [Full Text] [Related]
15. Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
Allison Stewart C; Tong P; Cardnell RJ; Sen T; Li L; Gay CM; Masrorpour F; Fan Y; Bara RO; Feng Y; Ru Y; Fujimoto J; Kundu ST; Post LE; Yu K; Shen Y; Glisson BS; Wistuba I; Heymach JV; Gibbons DL; Wang J; Byers LA
Oncotarget; 2017 Apr; 8(17):28575-28587. PubMed ID: 28212573
[TBL] [Abstract] [Full Text] [Related]
16. A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated cancers.
Jung M; Russell AJ; Liu B; George J; Liu PY; Liu T; DeFazio A; Bowtell DD; Oberthuer A; London WB; Fletcher JI; Haber M; Norris MD; Henderson MJ
Cancer Res; 2017 Feb; 77(4):971-981. PubMed ID: 27923830
[TBL] [Abstract] [Full Text] [Related]
17. GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.
Cox DG; Curtit E; Romieu G; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Deleuze JF; Pauporté I; Thomas G; Pivot X
Oncotarget; 2016 Nov; 7(47):77358-77364. PubMed ID: 27764800
[TBL] [Abstract] [Full Text] [Related]
18. Nutritional risk factors and status of serum 25(OH)D levels in patients with breast cancer: A case control study in India.
Sofi NY; Jain M; Kapil U; Seenu V; Kamal VK; Pandey RM
J Steroid Biochem Mol Biol; 2018 Jan; 175():55-59. PubMed ID: 27687737
[TBL] [Abstract] [Full Text] [Related]
19. Familial risks and estrogen receptor-positive breast cancer in Hong Kong Chinese women.
Tse LA; Li M; Chan WC; Kwok CH; Leung SL; Wu C; Yu IT; Yu WC; Lao X; Wang X; Wong CK; Lee PM; Wang F; Yang XR
PLoS One; 2015; 10(3):e0120741. PubMed ID: 25756203
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNA related polymorphisms and breast cancer risk.
Khan S; Greco D; Michailidou K; Milne RL; Muranen TA; Heikkinen T; Aaltonen K; Dennis J; Bolla MK; Liu J; Hall P; Irwanto A; Humphreys K; Li J; Czene K; Chang-Claude J; Hein R; Rudolph A; Seibold P; Flesch-Janys D; Fletcher O; Peto J; dos Santos Silva I; Johnson N; Gibson L; Aitken Z; Hopper JL; Tsimiklis H; Bui M; Makalic E; Schmidt DF; Southey MC; Apicella C; Stone J; Waisfisz Q; Meijers-Heijboer H; Adank MA; van der Luijt RB; Meindl A; Schmutzler RK; Müller-Myhsok B; Lichtner P; Turnbull C; Rahman N; Chanock SJ; Hunter DJ; Cox A; Cross SS; Reed MW; Schmidt MK; Broeks A; Van't Veer LJ; Hogervorst FB; Fasching PA; Schrauder MG; Ekici AB; Beckmann MW; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Benitez J; Zamora PM; Perez JI; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Pharoah PD; Dunning AM; Shah M; Luben R; Brown J; Couch FJ; Wang X; Vachon C; Olson JE; Lambrechts D; Moisse M; Paridaens R; Christiaens MR; Guénel P; Truong T; Laurent-Puig P; Mulot C; Marme F; Burwinkel B; Schneeweiss A; Sohn C; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Andrulis IL; Knight JA; Tchatchou S; Mulligan AM; Dörk T; Bogdanova NV; Antonenkova NN; Anton-Culver H; Darabi H; Eriksson M; Garcia-Closas M; Figueroa J; Lissowska J; Brinton L; Devilee P; Tollenaar RA; Seynaeve C; van Asperen CJ; Kristensen VN; ; ; Slager S; Toland AE; Ambrosone CB; Yannoukakos D; Lindblom A; Margolin S; Radice P; Peterlongo P; Barile M; Mariani P; Hooning MJ; Martens JW; Collée JM; Jager A; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Giles GG; McLean C; Brauch H; Brüning T; Ko YD; ; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Swerdlow A; Ashworth A; Orr N; Jones M; Simard J; Goldberg MS; Labrèche F; Dumont M; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Kataja V; Kosma VM; Hartikainen JM; Mannermaa A; Hamann U; Chenevix-Trench G; Blomqvist C; Aittomäki K; Easton DF; Nevanlinna H
PLoS One; 2014; 9(11):e109973. PubMed ID: 25390939
[TBL] [Abstract] [Full Text] [Related]
[Next]
